# Sarepta (SRPT) — Analyst Forecast

SRPT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/srpt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 8 | 12 | 6 | 26 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $5.00 | $14.00 | $20.00 | 3 |

Last price $17.79 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | $17.00 |
| Oct 5, 2026 | HC Wainwright & Co. | Maintained | Sell | $5.00 |
| Sep 30, 2026 | JP Morgan | Maintained | Neutral | $20.00 |
| Sep 28, 2026 | Needham | Maintained | Underperform | — |
| Jul 9, 2026 | Piper Sandler | Maintained | Neutral | $20.00 |
| Jul 9, 2026 | Wolfe Research | Upgraded | Peer Perform → Outperform | $27.00 |
| Apr 16, 2026 | HC Wainwright & Co. | Maintained | Sell | $5.00 |
| Mar 26, 2026 | Needham | Maintained | Underperform | — |
| Mar 26, 2026 | Citigroup | Maintained | Sell | $13.00 |
| Mar 19, 2026 | Oppenheimer | Maintained | Outperform | $37.00 |
| Mar 13, 2026 | Mizuho | Maintained | Outperform | $31.00 |
| Mar 10, 2026 | Citigroup | Maintained | Sell | $9.00 |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Sell | $5.00 |
| Feb 27, 2026 | Wells Fargo | Maintained | Overweight | $38.00 |
| Jan 27, 2026 | HC Wainwright & Co. | Maintained | Sell | $5.00 |
| Jan 23, 2026 | Wedbush | Maintained | Outperform | $34.00 |
| Jan 14, 2026 | HC Wainwright & Co. | Maintained | Sell | $5.00 |
| Dec 9, 2025 | Wedbush | Initiated Coverage | Outperform | $32.00 |
| Nov 5, 2025 | Mizuho | Upgraded | Neutral → Outperform | $26.00 |
| Nov 5, 2025 | Wells Fargo | Maintained | Overweight | $45.00 |

## Frequently Asked Questions

### What is the price target for SRPT stock?

The average 12-month analyst price target for Sarepta (SRPT) is $14.00, with a high estimate of $20.00 and a low of $5.00, across 3 analysts.

### Is SRPT a buy, sell, or hold?

Analysts covering Sarepta currently average a Hold rating: 8 buy, 12 hold and 6 sell, from 26 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for SRPT?

The average price target of $14.00 implies 21.30% downside from the last price of $17.79.

### What is the latest analyst rating on SRPT?

On Oct 8, 2026, RBC Capital maintained Sarepta at Sector Perform with a price target of $17.00.

## Similar Stocks

- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock
- [CTMX](https://www.lighthorse.io/tickers/ctmx) — CytomX Therapeutics, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).